Skip to main content
. 2019 Jun 25;20(12):3108. doi: 10.3390/ijms20123108
ATP Adenosine Triphosphate
AMT Adsorptive-mediated Transcytosis
AD Alzheimer’s Disease
HIR-MAb Anti-human Insulin Receptor Monoclonal Antibody
TfR-MAb Anti-transferrin Receptor Monoclonal Antibody
AUC0T Area under the Plasma Drug Concentration-time Curve
ASL-MRI Arterial Spin labelling Coupled Magnetic Resonance Imaging
ABC ATP-binding Cassette Transporters
BBB Blood Brain Barrier
BCSFB Blood Cerebrospinal Fluid Barrier
Cbr Brain Concentration
BCRP Breast Cancer Resistance Protein
CMT Carrier-mediated Transcytosis
CNS Central Nervous System
CSF Cerebrospinal Fluid
Ð Dispersity Index
DCE-MRI Dynamic Contrast Enhanced Magnetic Resonance Imaging
EC Endothelial Cell
EPO Erythropoietin
GLUT Glucose Transporter
GFP Green Fluorescent Protein
IR Insulin Receptor
ISF Interstitial Fluid
l-DOPA l-3,4-dihydroxyphenylalanine
LAT Large Neutral Amino Acid Transporter
LBL Lipid Bilayer
LRP Lipoprotein Receptor-related Protein
LC-MS/MS Liquid Chromatography Coupled Mass Spectrometry
LDLR Low-density Lipoprotein Receptor
MB-FUS Microbubble-assisted Focused Ultrasound
MCT Monocarboxylate Transporter
MRP Multidrug Resistance-associated Protein
NPBA Nanoscopic Polymeric Brush Architectures
NMDA N-methyl-D-aspartate
Mn Number Average Molecular Weight
OTAP Organic-anion-transporting Polypeptide
PD Parkinson Disease
P-gp P-glycoprotein
PET Positron-emission Tomography
QTAP Quantitative-targeted Absolute Proteomics
RV Rabies Virus
RVG Rabies Virus Glycoprotein
RMT Receptor-mediated Transcytosis
ROMP Ring Opening Metathesis Polymerization
siRNA Small Interfering Ribonucleic Acid
SLC Solute Carrier Transporter Proteins
TJ Tight Junction
TfR Transferrin Receptor
FDA U S Food and Drug Administration
VFR Virulence Factor Receptor